COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS
Position in MRNA — Moderna, Inc.
CIK 1083190
HARRISBURG, PA
Position in MRNA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$4,115,155
+$1,730,063 QoQ
Shares Held
81,007
+0.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS holds $91,450,289 across 36 Biotechnology names. MRNA ranks #3 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,167 | $26,420,432 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,481 | $18,142,359 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
81,007 | $4,115,155 | |
| 4 | INCY |
Incyte Corp
|
38,941 | $3,665,126 | |
| 5 | BNTX |
BioNTech SE
|
38,319 | $3,405,792 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
112,973 | $3,129,352 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
15,225 | $2,878,286 | |
| 8 | EXEL |
Exelixis, Inc.
|
65,071 | $2,790,895 |
All Filings in MRNA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,115,155 | 81,007 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,385,092 | 80,878 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,147,893 | 83,155 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,302,909 | 83,469 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,195,509 | 77,443 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,993,967 | 72,005 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,921,227 | 73,638 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,696,775 | 73,236 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,759,912 | 72,822 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $7,224,246 | 72,642 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,876,738 | 66,577 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,946,884 | 57,176 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $8,602,015 | 56,010 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $10,031,417 | 55,848 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,819,082 | 49,210 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,197,497 | 50,385 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,130,327 | 47,198 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $11,244,964 | 44,275 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,936,918 | 44,008 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||